Eli Lilly Stock Enters Buy Zone as Nasdaq Recovers From Sell-Off
LLY rebounds into a buy range, securing spots on IBD Leaderboard and Big Cap 20 screens amid market rotation into healthcare. Eli Lilly (LLY) has re-entered a buy zone as the Nasdaq composite rebounds from Friday’s sell-off. The stock’s relative strength line is rising, po